These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20210087)

  • 1. Tableting of floating pellets with verapamil hydrochloride: influence of type of tablet press.
    Sawicki W; Łunio R
    Acta Pol Pharm; 2010; 67(1):103-6. PubMed ID: 20210087
    [No Abstract]   [Full Text] [Related]  

  • 2. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
    Sawicki W; Lunio R
    Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.
    Lunio R; Sawicki W
    Pharmazie; 2008 Oct; 63(10):731-5. PubMed ID: 18972835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid bed coating: the utility of dual programmable pumps for controlled gradient drug deposition on pellets.
    El-Malah Y; Nazzal S
    Int J Pharm; 2007 Jun; 337(1-2):361-4. PubMed ID: 17289315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous release of diclofenac sodium and papaverine hydrochloride from tablets and pellets using the flow-through cell apparatus described by dimensionless equations.
    Kasperek R
    Acta Pol Pharm; 2011; 68(2):261-72. PubMed ID: 21485300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of acrylic esters and methacyrlic esters on flotation of pellets and release rate of verapamil hydrochloride.
    Lunio R; Sawicki W
    Acta Pol Pharm; 2006; 63(1):69-74. PubMed ID: 17515332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
    Kostova B; Rachev D
    Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the type of cellulose on properties of multi-unit target releasing in stomach dosage form with verapamil hydrochloride.
    Sawicki W; Łunio R; Walentynowicz O; Kubasik-Juraniec J
    Acta Pol Pharm; 2007; 64(1):81-8. PubMed ID: 17665855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems.
    Malaterre V; Ogorka J; Loggia N; Gurny R
    Drug Dev Ind Pharm; 2009 Apr; 35(4):433-9. PubMed ID: 18989838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compressibility of gastroretentive pellets coated with Eudragit NE using a single-stroke and a rotary tablet press.
    Łunio R; Sawicki W; Skoczeń P; Walentynowicz O; Kubasik-Juraniec J
    Pharm Dev Technol; 2008; 13(4):323-31. PubMed ID: 18649222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
    Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production variables affecting characteristics of pellets in melt pelletization with wax combination in a laboratory scale spheronizer.
    Biswal S; Sahoo J; Murthy PN; Giradkar RP; Das S; Avari JG
    Acta Pharm; 2009 Jun; 59(2):199-210. PubMed ID: 19564144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation.
    Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D
    Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.
    Timmins P; Delargy AM; Howard JR
    Pharm Dev Technol; 1997 Feb; 2(1):25-31. PubMed ID: 9552428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of floating pellets with verapamil hydrochloride.
    Sawicki W; Głód J
    Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
    Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.